Partner Feature

cell membranes

Paid for by Aker BioMarine

The following content is provided by an advertiser or created on behalf of an advertiser. It is not written by the NutraIngredients Consolidated editorial team, nor does it necessarily reflect the opinions of NutraIngredients Consolidated.

For more information, please contact us here

From absorption to incorporation: Why cell membranes matter for whole-body health

Most omega-3 products are judged by what is on the label, such as how many milligrams of EPA and DHA are in a capsule.

But the more important biological question is what happens after those nutrients are taken in. Are they absorbed? Do they become incorporated into cell membranes? And do they reach the structures where they can exert their effects?

That is where Superba Krill® offers a differentiated story.

Why cell membranes matter

Every cell in the body is surrounded by a membrane, and these membranes regulate what enters and leaves the cell, how cells communicate, and how they respond to biological signals. Their composition is dynamic and can be influenced by nutrition over time.

Omega-3 fatty acids EPA and DHA, and choline in the form of phosphatidylcholine are two nutrients that are central to membrane structure and function.

EPA and DHA can become incorporated into membrane phospholipids, influencing membrane composition and properties such as fluidity, signaling, and inflammatory balance. Choline, meanwhile, forms the head group of phosphatidylcholines, one of the major structural phospholipids in human cell membranes.

Phospholipid bilayer

Superba Krill naturally brings these nutrients together in phospholipid form. EPA, DHA, and choline are structurally integrated within the phosphatidylcholine molecule, while astaxanthin occurs naturally alongside them in the oil.

This is why molecular form matters alongside dose. If EPA and DHA exert important biological effects once incorporated into cell membranes, understanding how effectively they reach and become part of these membranes is key to understanding their nutritional value.

Absorption is the first step

Omega-3 bioavailability is often assessed by measuring the rise in EPA and DHA in plasma after supplementation.

This is an important first step, and human clinical studies have consistently shown that krill oil effectively raises circulating EPA and DHA across diverse populations.1-5

A 2024 network meta-analysis of 22 randomized controlled trials further support strong omega-3 bioavailability with krill oil, particularly at lower EPA and DHA doses.6 More recently, a double-blind randomized controlled trial in healthy adults found higher circulating EPA and DHA with krill oil than with triglyceride-form fish oil at a comparable omega-3 dose.7

But plasma concentrations are relatively transient, and they do not directly tell us how much EPA and DHA have become incorporated into cell membranes.

That is where the Omega-3 Index comes in.

The Omega-3 Index measures EPA and DHA as a percentage of total fatty acids in red blood cell membranes. Because red blood cells have a lifespan of approximately 120 days, it provides a longer-term view of membrane omega-3 status rather than a snapshot influenced by a recent meal.

In other words, plasma tells us that omega-3 has entered circulation. The Omega-3 Index tells us how much EPA and DHA have become part of red blood cell membranes.

The biological proof point

This is where the Superba Krill evidence becomes particularly interesting.

In a randomized crossover study by Ramprasath and colleagues, krill oil and fish oil were given at the same omega-3 dose. The Omega-3 Index increased by 1.04 percentage points with krill oil versus 0.47 with fish oil – a 2.2-fold greater increase.8

A follow-up study examined whether phospholipid content itself could help explain this effect. Two krill oils delivered the same amount of EPA and DHA, but one contained twice as much phospholipid. The Omega-3 Index increased by 1.03 percentage points with the higher-phospholipid oil compared with 0.31 with the lower-phospholipid oil – a 3.3-fold difference.9

Taken together, these studies point in the same direction: omega-3 dose alone does not tell the full story. Phospholipid content is strongly associated with how effectively EPA and DHA become incorporated into red blood cell membranes.

This has an important implication, as equal omega-3 doses do not necessarily result in equal membrane incorporation.

This is not an isolated observation. Across clinical studies in healthy adults, trained athletes, older adults, people with osteoarthritis, people undergoing weight loss and adults with dry skin, Superba Krill has consistently increased the Omega-3 Index across a range of doses and study durations.

Why the Omega-3 Index matters

The Omega-3 Index tells us something fundamentally different from the amount of omega-3 consumed – or even the amount temporarily circulating in the blood. It reflects longer-term incorporation of EPA and DHA into red blood cell membranes. This is biologically relevant because once incorporated into phospholipid membranes, EPA and DHA can influence properties including membrane fluidity, cellular signaling, and inflammatory balance.

The Omega-3 Index also has broader health relevance. Developed by Harris and colleagues through cardiovascular research, it has been associated with cardiovascular risk, with values below 4% linked to higher risk and values of around 8% and above commonly proposed as a desirable range.10

Observational research has further associated higher red blood cell omega-3 status with favorable outcomes including lower estimated risk of fatal coronary heart disease, lower all-cause mortality, and lower levels of certain inflammatory biomarkers.6,11-14

At the same time, population data indicates that low omega-3 status remains widespread globally, with many populations at or below an Omega-3 Index of 4.15

This is what gives the Omega-3 Index practical relevance by turning omega-3 supplementation from an input measure into a measurable biological outcome.

For Superba Krill, that makes it an important biological proof point. Its EPA and DHA are not only consumed and absorbed, but clinical studies consistently show that they become incorporated into cell membranes.

Choline adds another dimension

Superba Krill also naturally delivers choline as phosphatidylcholine, a key structural component of cell membranes. Choline is an essential nutrient that contributes to normal lipid metabolism and to the maintenance of normal liver function.

This is relevant because choline intake is frequently below recommended levels. In the US, only around one in ten adults meets recommended intake levels, while population data from Europe also shows that intake commonly falls below recommendations across several countries.16-17

For Superba Krill, this adds another layer to the proposition. Phospholipid-bound EPA and DHA together with naturally occurring choline delivered within the same marine matrix – a multi-nutrient ingredient for cellular health.

A cellular foundation for whole-body health

This is where the cell membrane story becomes most powerful. Cell membranes are not confined to one organ or one health area. Every cell in the body has one, from cells in the heart, liver, and brain to those in muscles, joints, skin, and the immune system.

Superba Krill’s nutrients therefore act at the cellular level, a biological level that is inherently systemic.

Once incorporated, EPA and DHA can shape how cells function across these tissues, while choline contributes to membrane structure and processes including lipid metabolism, methylation, and neurotransmission.

This provides a biological explanation for Superba Krill’s broad relevance across the body.

The effects observed in different tissues are not simply a collection of unrelated outcomes. The same membrane-relevant nutrients are distributed throughout the body and incorporated into cells across multiple tissues and organs.

Superba Krill is supported by more than 60 published human clinical trials and more than 135 studies overall, spanning health areas including heart, liver, joints, skin, muscle, healthy ageing, sports nutrition, and weight management.

This does not mean that one single mechanism explains every clinical outcome. Rather, cellular membrane nutrition provides a shared biological foundation across tissues and organ systems.

In summary, when nutrients work at the cellular level, their relevance is not limited to one part of the body.

That is what makes the phospholipid advantage more than a compositional story. It is a story of systemic nutrient utilization, delivering key nutrients into cellular structures where they can become biologically relevant throughout the body.

Rethinking omega-3 value

Omega-3 products are often compared primarily on milligrams of EPA and DHA per capsule. That remains an important measure, but it is not the only one. The Omega-3 Index adds a biological outcome to the conversation.

It asks not only: how much omega-3 is consumed?

But also: how much becomes incorporated into cell membranes over time?

For brands and formulators, that shifts the conversation from input alone toward measurable biological response.

For Superba Krill, that distinction is central. Clinical research consistently shows that its phospholipid-form omega-3s increases the Omega-3 Index, while choline provides an additional membrane-relevant nutrient within the same natural matrix.

Not just taken in. Built in.

Not just taken in. Built in. That is the essence of the phospholipid advantage.

References

  1. Maki, KC.; et al. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutrition Research. 2009;29(9):609–615.
  2. Ulven, SM.; et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids. 2011;46(1):37–46.
  3. Schuchardt, JP.; et al. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations — a comparative bioavailability study of fish oil vs. krill oil. Lipids in Health and Disease. 2011;10:145.
  4. Yurko-Mauro, K.; et al. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study. Lipids in Health and Disease. 2015;14:99.
  5. Sung, HH.; et al. Postprandial long-chain n-3 PUFA response to krill oil and fish oil consumption in healthy women: a randomized controlled, single-dose, crossover study. Asia Pacific Journal of Clinical Nutrition. 2018;27(1):148–157.
  6. Pham, T-P-T.; et al. Comparison of omega-3 polyunsaturated fatty acids bioavailability in fish oil and krill oil: network meta-analyses. Food Chemistry X. 2024;24:101880.
  7. Loukil, I.; et al. Krill oil increases plasma omega-3 fatty acids more than fish oil in healthy adults: a double-blind randomized controlled trial. American Journal of Clinical Nutrition. 2026:101346.
  8. Ramprasath, VR.; et al. Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil. Lipids in Health and Disease. 2013;12:178.
  9. Ramprasath, VR.; et al. Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil. Lipids in Health and Disease. 2015;14:142.
  10. Harris, WS. The Omega-3 Index: clinical utility for therapeutic intervention. Current Cardiology Reports. 2010;12(6):503–508.
  11. McBurney, MI.; et al. Using an erythrocyte fatty acid fingerprint to predict risk of all-cause mortality: the Framingham Offspring Cohort. American Journal of Clinical Nutrition. 2021;114(4):1447–1454.
  12. Harris, WS.; et al. The Omega-3 Index and relative risk for coronary heart disease mortality: estimation from 10 cohort studies. Atherosclerosis. 2017;262:51–54.
  13. Fontes JD.; et al. Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort. Atherosclerosis. 2015;240(2):431–436.
  14. Harris, WS.; et al. The Omega-3 Index: a new risk factor for death from coronary heart disease? Preventive Medicine. 2004;39(1):212–220.
  15. Schuchardt, JP.; et al. Omega-3 world map: 2024 update. Progress in Lipid Research. 2024;95:101286.
  16. Wallace, TC.; et al. Usual choline intakes are associated with egg and protein food consumption in the United States. Nutrients. 2017;9(8):839.
  17. Vennemann, FBC.; et al. Dietary intake and food sources of choline in European populations. British Journal of Nutrition. 2015;114(12):2046–2055.

More from Aker BioMarine

Related Resources

Krill oil supports six key areas of healthy aging

Krill oil supports six key areas of healthy aging

Paid for by Aker BioMarine

White Paper

The global population is getting older—according to WHO by 2050 the world’s population over 60 years will double and the population above 80 years will triple. As people live well beyond retirement age, they are taking a proactive approach to staying...